Document and Entity Information
Document and Entity Information | 3 Months Ended |
Nov. 30, 2017shares | |
Document Type | 10-Q |
Amendment Flag | false |
Document Period End Date | Nov. 30, 2017 |
Trading Symbol | enrt |
Entity Registrant Name | Enertopia Corp. |
Entity Central Index Key | 1,346,022 |
Current Fiscal Year End Date | --08-31 |
Entity Filer Category | Smaller Reporting Company |
Entity Common Stock, Shares Outstanding | 104,898,031 |
Entity Current Reporting Status | Yes |
Entity Voluntary Filers | No |
Entity Well Known Seasoned Issuer | No |
Document Fiscal Year Focus | 2,018 |
Document Fiscal Period Focus | Q1 |
UNAUDITED CONDENSED INTERIM BAL
UNAUDITED CONDENSED INTERIM BALANCE SHEETS - USD ($) | Nov. 30, 2017 | Aug. 31, 2017 |
Current | ||
Cash and cash equivalents | $ 51,593 | $ 150,870 |
Accounts receivable | 14,209 | 9,060 |
Prepaid expenses and deposit | 60,533 | 18,782 |
Total current assets | 126,335 | 178,712 |
Non-Current | ||
Long term investments | 1 | 1 |
Lithium Technology | 12,500 | 12,500 |
Total Assets | 138,836 | 191,213 |
Current | ||
Accounts payable | 289,191 | 287,706 |
Shares Subscription Received | 0 | 0 |
Due to related parties | 148,385 | 141,035 |
Total Current Liabilities | 437,576 | 428,741 |
STOCKHOLDERS' EQUITY | ||
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 104,898,031 common shares at November 30, 2017 and August 31,2017: 102,298,031 | 104,899 | 102,299 |
Additional paid-in capital | 13,031,466 | 12,901,936 |
Deficit accumulated during the exploration stage | (13,435,105) | (13,241,763) |
Total Stockholders' Equity | (298,740) | (237,528) |
Total Liabilities and Stockholders' Equity | $ 138,836 | $ 191,213 |
UNAUDITED CONDENSED INTERIM BA3
UNAUDITED CONDENSED INTERIM BALANCE SHEETS (Parenthetical) - $ / shares | Nov. 30, 2017 | Aug. 31, 2017 |
Common Stock, Shares Authorized | 200,000,000 | 200,000,000 |
Common Stock, Par Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Issued | 104,898,031 | 102,298,031 |
Common Stock, Shares, Outstanding | 104,898,031 | 102,298,031 |
CONDENSED INTERIM STATEMENTS OF
CONDENSED INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) | COMMON STOCK [Member] | ADDITIONAL PAID-IN CAPITAL [Member] | DEFICIT ACCUMULATED [Member] | Total |
Beginning Balance at Aug. 31, 2016 | $ 89,528 | $ 12,214,934 | $ (12,440,597) | $ (136,135) |
Beginning Balance (Shares) at Aug. 31, 2016 | 89,528,460 | |||
Stock Based Compensation | 39,646 | 227,428 | ||
Shares issued for private placement on September 23 | $ 3,859 | 93,792 | 97,651 | |
Shares issued for private placement on September 23 (Shares) | 3,858,571 | |||
Shares issued for Definitive Agreement on October 7 | $ 175 | 6,825 | 7,000 | |
Shares issued for Definitive Agreement on October 7 (Shares) | 175,000 | |||
Comprehensive income (loss): | (165,712) | (165,712) | ||
Ending Balance at Nov. 30, 2016 | $ 93,562 | 12,355,197 | (12,606,309) | (157,550) |
Ending Balance (Shares) at Nov. 30, 2016 | 93,562,031 | |||
Stock Based Compensation | 187,782 | 187,782 | ||
Shares issued for Private Placement on January 20 | $ 1,000 | 28,600 | 29,600 | |
Shares issued for Private Placement on January 20 (Shares) | 1,000,000 | |||
Shares issued for Private Placement on February 28 | $ 4,250 | 115,119 | 119,369 | |
Shares issued for Private Placement on February 28 (Shares) | 4,250,000 | |||
Warrant conversion on April 21 | $ 96 | 5,590 | 5,686 | |
Warrant conversion on April 21 (Shares) | 95,500 | |||
Warrant conversion on April 28 | $ 167 | 11,488 | 11,655 | |
Warrant conversion on April 28 (Shares) | 166,500 | |||
Shares issued for Private Placement on April 28 | $ 3,224 | 198,161 | 201,385 | |
Shares issued for Private Placement on April 28 (Shares) | 3,224,000 | |||
Comprehensive income (loss): | (635,454) | (635,454) | ||
Ending Balance at Aug. 31, 2017 | $ 102,299 | 12,901,936 | (13,241,763) | (237,528) |
Ending Balance (Shares) at Aug. 31, 2017 | 102,298,031 | |||
Stock Based Compensation | 31,237 | 31,237 | ||
Shares issued for Private Placement on November 1 | $ 2,600 | 98,293 | 100,893 | |
Shares issued for Private Placement on November 1 (Shares) | 2,600,000 | |||
Comprehensive income (loss): | (193,342) | (193,342) | ||
Ending Balance at Nov. 30, 2017 | $ 104,899 | $ 13,031,466 | $ (13,435,105) | $ (298,740) |
Ending Balance (Shares) at Nov. 30, 2017 | 104,898,031 |
CONDENSED INTERIM STATEMENTS O5
CONDENSED INTERIM STATEMENTS OF OPERATIONS (unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Revenue | ||
Net Sales | $ 0 | $ 0 |
Cost of Product Sales | 0 | 0 |
Gross Profit | 0 | 0 |
Expenses | ||
Accounting and audit | 6,118 | 14,800 |
Sales & Marketing | 0 | 0 |
Bank charges and interest expense | 357 | 1,252 |
Consulting | 10,700 | 39,128 |
Mineral exploration costs | 0 | 31,509 |
Fees and dues | 11,804 | 11,268 |
Insurance | 3,002 | 3,548 |
Investor relations | 12,651 | 27,255 |
Legal and professional | 3,748 | 6,336 |
Office and miscellaneous | 1,775 | (2,379) |
Research and Development | 108,748 | 0 |
Rent | 1,362 | 4,724 |
Stock based compensation | 31,237 | 39,646 |
Telephone | (203) | 697 |
Training & Conferences | 0 | 0 |
Travel | 2,631 | 527 |
Total expenses | 193,931 | 178,311 |
Loss for the period before other items | (193,931) | (178,311) |
Other income (expense) | ||
Foreign exchange gain | 589 | 0 |
Gain on marketable securities | 0 | 12,599 |
Net loss and comprehensive loss for the period | $ (193,342) | $ (165,712) |
Basic and diluted loss per share | $ 0 | $ 0 |
Weighted average number of common shares outstanding - basic and diluted | 102,504,606 | 81,823,821 |
CONDENSED INTERIM STATEMENTS O6
CONDENSED INTERIM STATEMENTS OF CASH FLOWS (unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Cash flows used in operating activities | ||
Net Income (loss) | $ (193,342) | $ (165,712) |
Changes to reconcile net loss to net cash used in operating activities | ||
Stock based compensation | 31,237 | 39,646 |
Gain on owned securities | 0 | (12,599) |
Change in non-cash working capital items: | ||
Accounts receivable | (5,149) | (2,599) |
Prepaid expenses and deposit | (41,751) | 26,759 |
Accounts payable and accrued liabilities | 1,485 | (13,404) |
Due to related parties | 7,350 | 11,086 |
Net cash (used in) operating activities | (200,170) | (116,823) |
Cash flows from (used in) investing activities | ||
Proceeds from sale of marketable securities | 0 | 25,979 |
Mineral resource properties acquisition | 0 | (5,000) |
Net cash from investing activities | 0 | 20,979 |
Cash flows from financing activities | ||
Net proceeds from subscriptions received | 100,893 | 97,651 |
Net cash from financing activities | 100,893 | 97,651 |
Increase (Decrease) in cash and cash equivalents | (99,277) | 1,807 |
Cash and cash equivalents, beginning of period | 150,870 | 31,034 |
Cash and cash equivalents, end of period | 51,593 | 32,841 |
Supplemental information of cash flows | ||
Interest paid in cash | 0 | 0 |
Income taxes paid in cash | $ 0 | $ 0 |
ORGANIZATION
ORGANIZATION | 3 Months Ended |
Nov. 30, 2017 | |
ORGANIZATION [Text Block] | 1. ORGANIZATION The unaudited condensed interim financial statements for the period ended November 30, 2017 included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed interim financial statements should be read in conjunction with the August 31, 2017 audited annual financial statements and notes thereto. The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewal energy operations to its planned renewal energy operations and natural resource acquisition and development. In late summer of 2013, the Company had another business sector in alternative health and wellness. During spring of 2016, the Company shifted its strategic plan to natural resource acquisitions and Lithium brine extraction technology. The Company office is located in Kelowna, B.C., Canada. |
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY | 3 Months Ended |
Nov. 30, 2017 | |
GOING CONCERN UNCERTAINTY [Text Block] | 2. GOING CONCERN UNCERTAINTY The accompanying unaudited condensed interim financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company had a working capital deficit of $311,241 for the quarter ended November 30, 2017 [deficit of $250,029 for the year ended August 31, 2017]. The Company incurred a net loss of $193,342 for the three months ended November 30, 2017 [net loss of $165,712 for the three months ended November 30, 2016] and as at November 30, 2017 has incurred cumulative losses of $13,435,105 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to be adequately financed on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company’s shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These unaudited interim condensed financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying unaudited condensed interim financial statements. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Nov. 30, 2017 | |
SIGNIFICANT ACCOUNTING POLICIES [Text Block] | 3. SIGNIFICANT ACCOUNTING POLICIES a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2017. b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to revenue recognition, inventory valuation, and stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. c) Recently Adopted Accounting Pronouncements In May 2015, the FASB issued guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share practical expedient. The guidance is effective for the Company in the first quarter of fiscal 2017 and early adoption is permitted. Adoption of the new guidance, effective for the quarter beginning September 1, 2017, had no impact on the Company’s balance sheets or statements of operations or cash flows. d) New Accounting Pronouncements Restricted Cash In November 2016, ASU No. 2016-18 was issued related to the inclusion of restricted cash in the statement of cash flows. This new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The adoption of this guidance will result in the inclusion of the restricted cash balances within the overall cash balance and removal of the changes in restricted cash activity, which are currently recognized in Other financing activities, on the Statements of Consolidated Cash Flows. Furthermore, an additional reconciliation will be required to reconcile Cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets to sum to the total shown in the Statements of Consolidated Cash Flows. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Intra-Entity Transfers In October 2016, ASU No. 2016-16 was issued related to the intra-entity transfers of assets other than inventory. This new guidance requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Statement of Cash Flows In August 2016, ASU No. 2016-15 was issued related to the statement of cash flows. This new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Leases In February 2016, ASU No. 2016-02 was issued related to leases. The new guidance modifies the classification criteria and requires lessees to recognize the assets and liabilities arising from most leases on the balance sheet. This update is effective in fiscal years, including interim periods, beginning after December 15, 2018 and early adoption is permitted. The Company is currently evaluating the updated guidance. Investments In January 2016, ASU No. 2016-01 was issued related to financial instruments. The new guidance requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. This new guidance also updates certain disclosure requirements for these investments. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the updated guidance. Revenue recognition In May 2014, ASU No. 2014-09 was issued related to revenue from contracts with customers. This ASU was further amended in August 2015, March 2016, April 2016, May 2016 and December 2016 by ASU No. 2015-14, No. 2016- 08, No. 2016-10, No. 2016-12 and No. 2016-20, respectively. The new standard provides a five-step approach to be applied to all contracts with customers and also requires expanded disclosures about revenue recognition. In August 2015, the effective date was deferred to reporting periods, including interim periods, beginning after December 15, 2017 and will be applied retrospectively. Early adoption is not permitted. The Company is currently evaluating the updated guidance. |
MARKETABLE SECURITIES
MARKETABLE SECURITIES | 3 Months Ended |
Nov. 30, 2017 | |
MARKETABLE SECURITIES [Text Block] | 4. MARKETABLE SECURITIES As at November 30, 2017 and August 31, 2017, the Company held no marketable securities. During the quarter end November 30, 2016, the Company disposed of 134,000 common shares of Lexaria. The proceeds from the sales of sales were $25,979. The Company recorded a gain of $12,599 in profit and loss on the sale of marketable securities. |
LONG TERM INVESTMENTS
LONG TERM INVESTMENTS | 3 Months Ended |
Nov. 30, 2017 | |
LONG TERM INVESTMENTS [Text Block] | 5. LONG TERM INVESTMENTS Global Solar Water Power Systems Inc. (“GSWPS”) During the year ended August 31, 2013, based on the management’s assessment of GSWPS’s current operations, the Company decided to write down long-term investment in GSWPS to $1. |
MINERAL PROPERTY
MINERAL PROPERTY | 3 Months Ended |
Nov. 30, 2017 | |
MINERAL PROPERTY [Text Block] | 6. MINERAL PROPERTY During the year ended August 30, 2017 the company staked lode and placer claims of BLM lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. The claims are in good standing until August 31, 2018. |
LITHIUM TECHNOLOGY
LITHIUM TECHNOLOGY | 3 Months Ended |
Nov. 30, 2017 | |
LITHIUM TECHNOLOGY [Text Block] | 7. LITHIUM TECHNOLOGY On August 15, 2016, a binding Letter of Intent (“LOI’) was signed by Enertopia and Genesis Water Technologies, Inc. ("GWT") with regard to the acquisition by Enertopia of the exclusive worldwide licensing rights (the "Licensing Rights") by Enertopia of all of the technology used in the process of recovering and extraction of battery grade lithium carbonate powder Li2CO3 grading 99.5% or higher purity from brine solutions. Upon the execution of this LOI, Enertopia issued 250,000 common shares valued at $12,500 to GWT. On December 6, 2016, and amended on October 9, 2017, Enertopia and GWT signed a Definitive Commercial Agreement with regard to the acquisition by Enertopia of the exclusive licensing rights in the United States of America, Argentina, Bolivia and Chile of all of the technology used in the process of recovering and extraction of battery grade lithium carbonate powder Li2CO3 grading 99.5% or higher purity from brine solutions. The following are key points of the terms of the formal Definitive Commercial Agreement: a) Enertopia to pay within 30 days to GWT $10,000 (paid) for the bench testing of four lithium brine samples to confirm the June 2016 feasibility report. During the period ended November 30, 2017, the Company signed a Lab Testing Service Agreement with GWT and paid $96,475 for the purpose of additional bench testing services with a further $96,475 due December 15, 2017 (paid subsequent to the three month period ended November 30, 2017) plus materials costs of $8,998 (paid subsequent to the three month period ended November 30, 2017). Within 30 days of successful independent 3 rd b) Upon successful test pilot facility results, start the construction of commercial Lithium recovery production facility. c) Upon receipt of a patent for the process for extracting lithium from wastewater, Enertopia will issue 250,000 common shares to GWT. d) GWT has granted Enertopia exclusive rights and relicensing rights to the usage of GWT’s patent pending technology covering United States of America, Argentina, Bolivia and Chile as per the Commercialization Agreement in return for 10 per cent of net sales royalty payments for battery grade Lithium Carbonate Li2CO3 produced. e) In order to maintain its exclusive rights, Enertopia will need to make the following minimal payments to GWT on the anniversary of bench testing achieving 99.5% battery grade Li2CO3 recovery verified by independent laboratory testing: a. On or before the first anniversary, the greater of 10 per cent of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or $50,000 ; b. On or before the second anniversary, the greater of 10 per cent of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or $150,000 ; c. On or before the third anniversary annually until the seventh anniversary, the greater of 10 per cent of Enertopia net Lithium Carbonate Li2CO3 sales from brine sources or $200,000 ; d. Right of first refusal to renew exclusive rights and relicensing rights for another 10 years after the first seven year licensing period on the same net sales terms as those of 2023 or $250,000 per annum. |
RELATED PARTY TRANSACTION
RELATED PARTY TRANSACTION | 3 Months Ended |
Nov. 30, 2017 | |
RELATED PARTY TRANSACTION [Text Block] | 8. RELATED PARTIES TRANSACTION For the three months ended November 30, 2017, the Company was party to the following related party transactions: • Incurred $10,500 (November 30, 2016: $19,500) to the President of the Company in consulting fees. • Incurred CAD$Nil (November 30, 2016: CAD$22,500) in consulting fees to a company controlled by the former CFO of the Company. • $148,385 (August 31, 2017: $141,035) was payable to the President of the Company. • Incurred share based compensation expenses of $19,523 in relation to stock options issued to a director of the Company (November 30, 2016: $nil). The related party transactions are recorded at the exchange amount established and agreed to between the related parties. |
COMMON STOCK
COMMON STOCK | 3 Months Ended |
Nov. 30, 2017 | |
COMMON STOCK [Text Block] | 9. COMMON STOCK On September 23, 2016, the Company closed the final tranche of a private placement of 3,858,571 units at a price of CAD$0.035 per unit for gross proceeds of CAD$135,050 (equivalent of $100,037). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price $0.07. A cash finders’ fee of CAD$4,830 and 138,000 full broker warrants that expire September 23, 2018 was paid to Canaccord Genuity and Leede Jones Gable Inc. On October 7, 2016, the Company issued 175,000 shares with a fair value of $7,000 per the definitive agreement signed on May 12, 2016 to purchase a 100% interest in approximately 2,560 acres of placer mining claims in Churchill, Lander and Nye Counties Nevada, USA. Also see Note 7. The value of the shares was capitalized to Mineral Properties. On January 20, 2017, the Company closed the first tranche of a private placement of 1,000,000 units at a price of CAD$0.04 per unit for gross proceeds of CAD$40,000 (equivalent of $29,630). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finders’ fee of CAD$800 and 20,000 full broker warrants that expire January 20, 2019 was paid to Leede Jones Gable Inc. On February 28, 2017, the Company closed the first tranche of a private placement of 4,250,000 units at a price of CAD$0.04 per unit for gross proceeds of CAD$170,000 (equivalent of $125,926). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finders’ fee of CAD$11,100 and 227,500 full broker warrants that expire February 28, 2019 was paid to Leede Jones Gable Inc., Canaccord Genuity and Duncan McKay. On April 21, 2017, the Company issued 95,500 shares for gross proceeds of $5,685 from the exercise of warrants of previous financings at $0.05 and $0.07. On April 30, 2017, the Company issued 166,500 shares for gross proceeds of $11,655 from the exercise of warrants from a previous financing at $0.07. On April 30, 2017, the Company closed the final tranche of a private placement of 3,224,000 units at a price of CAD$0.09 per unit for gross proceeds of CAD$290,160 (equivalent of $214,933). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.12. A cash finders’ fee of CAD$20,736 and 230,400 full broker warrants that expire April 28, 2019 was paid to Leede Jones Gable and Canaccord Genuity. On November 1, 2017, the Company closed the first tranche of a private placement of 2,600,000 units at a price of CAD$0.05 per unit for gross proceeds of CAD$130,000 (equivalent of $100,893). Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. As at November 30, 2017 the Company had 104,898,031 shares issued and outstanding and as at August 31, 2017, the Company had 102,298,031 shares issued and outstanding. |
STOCK OPTIONS AND WARRANTS
STOCK OPTIONS AND WARRANTS | 3 Months Ended |
Nov. 30, 2017 | |
STOCK OPTIONS AND WARRANTS [Text Block] | 10. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company’s 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company’s 2007 Equity compensation plan and the Company’s 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On October 23, 2015, the Company granted 1,850,000 stock options to directors, officers and consultant of the Company with an exercise price of $0.05 vested immediately, expiring October 23, 2020. On February 4, 2016, the Company granted 100,000 stock options to Advisor of the Board of the Company with an exercise price of $0.05 vested immediately, expiring February 4, 2021. On September 19, 2016, the Company granted 800,000 stock options to consultant of the Company with an exercise price of $0.07 vested immediately, expiring September 19, 2021. On January 20, 2017, the Company granted 1,535,000 stock options to directors, officers and consultant of the Company with an exercise price of $0.07 vested immediately, expiring January 20, 2022. On January 31, 2017, the Company granted 1,500,000 stock options to consultant of the Company with an exercise price of $0.07 vested immediately, expiring January 31, 2022. On May 2, 2017, the Company granted 500,000 stock options to consultant of the Company with an exercise price of $0.10, vested immediately, expiring May 2, 2022. On November 1, 2017, the Company granted 800,000 stock options to a director and consultant of the Company with an exercise price of $0.05, expiring November 2, 2022. For the three months ended November 30, 2017, the Company recorded $31,237 (November 30, 2016 – $39,646) stock based compensation expenses. A summary of the changes in stock options for the three months ended November 30, 2017 is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2017 7,295,000 $ 0.07 Granted 800,000 0.05 Balance, November 30, 2017 8,095,000 $ 0.07 The fair value of options granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: November 30, 2017 November 30, 2016 Expected volatility 204% 223% Risk-free interest rate 2.03% 1.22% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.04 $0.05 The Company has the following options outstanding and exercisable. November 30, 2017 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.05 800,000 4.91 years $0.10 500,000 4.42 years $0.07 1,500,000 4.17 years $0.07 1,535,000 4.14 years $0.07 800,000 3.81 years $0.05 1,460,000 * 2.90 years $0.10 1,000,000 1.93 years $0.06 500,000 0.93 years 8,095,000 3.40 years *Subsequent to the three month period ended November 30, 2017, 240,000 options were exercised for net proceeds of $12,000. August 31, 2017 Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.10 500,000 4.67 years $0.07 1,500,000 4.42 years $0.07 1,535,000 4.39 years $0.07 800,000 4.05 years $0.05 1,460,000 3.15 years $0.10 1,000,000 2.18 years $0.06 500,000 1.18 years 7,295,000 3.43 years *The aggregate intrinsic value for options outstanding and exercisable as at November 30, 2017 was $Nil. Warrants On December 16, 2015, the Company submitted to the CSE the Form 13 for extending two classes of warrants by two years with all other terms and conditions remaining the same. The Company approved the expiry extension from January 31, 2016 till January 31, 2018 on 2,167,160 warrants that remain outstanding as of November 30, 2017 from the non-brokered private placement that closed on January 31, 2014. The Company approved the expiry extension from February 13, 2016 until February 13, 2018 on 7,227,340 warrants that remain outstanding as of November 30, 2017 from the non-brokered private placement that closed on February 13, 2014. The warrants were evaluated against ASC 815 Derivatives and Hedging, and determined to be equity instrument at initial recognition. On February 28, 2017, the Company signed a Letter of Engagement with Adam Mogil and issued 1,000,000 warrant options to convert to 1,000,000 common shares to Adam Mogil to provide corporate services. The warrants have an exercise price of $0.09 and expire August 28, 2017. The fair value of the warrants granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: expected volatility: 182%, risk-free interest rate: 1.22%, expected life: 0.50 years, dividend yield: 0.00% . The Company has recorded $29,168 in stock based compensation expense. On April 21, 2017, the Company issued 95,500 shares for gross proceeds of $5,685 from the exercise of warrants of previous financings at $0.05 and $0.07. On April 30, 2017, the Company issued 166,500 shares for gross proceeds of $11,655 from the exercise of warrants from a previous financing at $0.07. During the year ended August 31, 2017, the Company issued 12,332,571 warrants attached to units issued in multiple private placements, see Note 9 for disclosure of individual amounts and terms of warrants by private placement. In addition, the Company issued 615,900 brokers warrants in connection with these private placements, also disclosed in Note 9. The fair value of the brokers warrants was $33,213, recorded as share issuance costs off-setting the gross proceeds of private placements in additional-paid-in-capital, and was calculated using the Black Scholes option pricing model, with the following weighted average assumptions: expected volatility 168%, risk-free interest rate: 1.14%, expected life: 2 years, dividend yield: 0.00% . During the three month period ended November 30, 2017, the Company issued 2,600,000 warrants attached to units in a private placement, see Note 9 for disclosure of the terms of the warrants. A summary of warrants as at November 30, 2017 and August 31, 2017 is as follows: Warrant Outstanding Weighted Average Number of warrant Exercise Price Balance, August 31, 2017 39,191,810 $ 0.09 Expired - - Issued 2,600,000 0.06 Balance, November 30, 2017 41,791,810 $ 0.09 Number Exercise Expiry Outstanding 1 Price Date 2,600,000 $0.06 November 1, 2019 3,454,400 $0.12 April 28, 2019 4,477,500 $0.06 February 28, 2019 1,020,000 $0.06 January 20,2019 2,167,160 $0.15 January 31, 2018 7,227,340 $0.15 February 13, 2018 1,787,640 $0.15 January 30, 2018 637,200 $0.10 and $0.15 after 24 months March 12, 2018 6,882,666 $0.05 and $0.10 after 18 months May 20, 2019 3,253,333 $0.05 and $0.10 after 18 months June 8, 2019 4,288,000 $0.07 August 9, 2018 3,996,571 $0.07 September 23, 2018 41,791,810 1. Each warrant entitles a holder to purchase one common share. |
COMMITMENTS - OTHER
COMMITMENTS - OTHER | 3 Months Ended |
Nov. 30, 2017 | |
COMMITMENTS - OTHER [Text Block] | 11. COMMITMENTS - OTHER (a) The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $5,000 per month plus goods and services tax (“GST”) on a continuing basis. Effective March 1, 2014, the Company entered into a new consulting contract with the consulting services at $6,500 per month plus GST. Effective July 1, 2017, the Company entered into a new consulting contract for consulting service at $3,500 per month plus GST. (b) On September 19, 2016, the Company entered into a one year Investor Relations Consulting agreement with Duncan McKay. Based on the terms of the agreement, Mr. McKay can earn up to a maximum of 10% commissions on capital raised. |
SEGMENTED INFORMATION
SEGMENTED INFORMATION | 3 Months Ended |
Nov. 30, 2017 | |
SEGMENTED INFORMATION [Text Block] | 12. SEGMENTED INFORMATION As at November 30, 2017 and August 31, 2017, the Company is operating its business in one reportable segment: natural resource acquisitions. All of the Company’s material long-lived assets are located in the United States. |
COMPARATIVE FIGURES
COMPARATIVE FIGURES | 3 Months Ended |
Nov. 30, 2017 | |
COMPARATIVE FIGURES [Text Block] | 13. COMPARATIVE FIGURES Certain comparative figures have been reclassified to conform to the current period's presentation. These reclassifications did not affect prior periods' net losses. |
SUBSEQUENT EVENT
SUBSEQUENT EVENT | 3 Months Ended |
Nov. 30, 2017 | |
SUBSEQUENT EVENT [Text Block] | 14. SUBSEQUENT EVENT On December 8, 2017, the Company closed the second tranche of a private placement of 3,954,000 units at a price of CAD$0.05 per unit for gross proceeds of CAD $197,700. Each unit consists of one common share of the Company and one non-transferable share purchase warrant, each full warrant entitling the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. A cash finder’s fee of CAD $12,770 and 230,400 full broker warrants was paid to third parties. Each full broker warrant entitles the holder to purchase one additional common share of the Company for a period of 24 months from the date of issuance, at a purchase price of $0.06. |
Summary of Significant Accounti
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Nov. 30, 2017 | |
Basis of Presentation [Policy Text Block] | a) Basis of Presentation The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2017. |
Accounting Estimates [Policy Text Block] | b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to revenue recognition, inventory valuation, and stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. |
Recently Adopted Accounting Pronouncements [Policy Text Block] | c) Recently Adopted Accounting Pronouncements In May 2015, the FASB issued guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share practical expedient. The guidance is effective for the Company in the first quarter of fiscal 2017 and early adoption is permitted. Adoption of the new guidance, effective for the quarter beginning September 1, 2017, had no impact on the Company’s balance sheets or statements of operations or cash flows. |
New Accounting Pronouncements [Policy Text Block] | d) New Accounting Pronouncements Restricted Cash In November 2016, ASU No. 2016-18 was issued related to the inclusion of restricted cash in the statement of cash flows. This new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The adoption of this guidance will result in the inclusion of the restricted cash balances within the overall cash balance and removal of the changes in restricted cash activity, which are currently recognized in Other financing activities, on the Statements of Consolidated Cash Flows. Furthermore, an additional reconciliation will be required to reconcile Cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets to sum to the total shown in the Statements of Consolidated Cash Flows. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Intra-Entity Transfers In October 2016, ASU No. 2016-16 was issued related to the intra-entity transfers of assets other than inventory. This new guidance requires entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Statement of Cash Flows In August 2016, ASU No. 2016-15 was issued related to the statement of cash flows. This new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating this guidance and the impact it will have on the Financial Statements and disclosures. Leases In February 2016, ASU No. 2016-02 was issued related to leases. The new guidance modifies the classification criteria and requires lessees to recognize the assets and liabilities arising from most leases on the balance sheet. This update is effective in fiscal years, including interim periods, beginning after December 15, 2018 and early adoption is permitted. The Company is currently evaluating the updated guidance. Investments In January 2016, ASU No. 2016-01 was issued related to financial instruments. The new guidance requires entities to measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in fair value in net income. This new guidance also updates certain disclosure requirements for these investments. This update is effective in fiscal years, including interim periods, beginning after December 15, 2017 and early adoption is not permitted. The Company is currently evaluating the updated guidance. Revenue recognition In May 2014, ASU No. 2014-09 was issued related to revenue from contracts with customers. This ASU was further amended in August 2015, March 2016, April 2016, May 2016 and December 2016 by ASU No. 2015-14, No. 2016- 08, No. 2016-10, No. 2016-12 and No. 2016-20, respectively. The new standard provides a five-step approach to be applied to all contracts with customers and also requires expanded disclosures about revenue recognition. In August 2015, the effective date was deferred to reporting periods, including interim periods, beginning after December 15, 2017 and will be applied retrospectively. Early adoption is not permitted. The Company is currently evaluating the updated guidance. |
STOCK OPTIONS AND WARRANTS (Tab
STOCK OPTIONS AND WARRANTS (Tables) | 3 Months Ended | 12 Months Ended |
Nov. 30, 2017 | Aug. 31, 2017 | |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2017 7,295,000 $ 0.07 Granted 800,000 0.05 Balance, November 30, 2017 8,095,000 $ 0.07 | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | November 30, 2017 November 30, 2016 Expected volatility 204% 223% Risk-free interest rate 2.03% 1.22% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.04 $0.05 | |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.05 800,000 4.91 years $0.10 500,000 4.42 years $0.07 1,500,000 4.17 years $0.07 1,535,000 4.14 years $0.07 800,000 3.81 years $0.05 1,460,000 * 2.90 years $0.10 1,000,000 1.93 years $0.06 500,000 0.93 years 8,095,000 3.40 years | Options outstanding and exercisable Number Remaining Exercise prices of shares contractual life $0.10 500,000 4.67 years $0.07 1,500,000 4.42 years $0.07 1,535,000 4.39 years $0.07 800,000 4.05 years $0.05 1,460,000 3.15 years $0.10 1,000,000 2.18 years $0.06 500,000 1.18 years 7,295,000 3.43 years |
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] | Warrant Outstanding Weighted Average Number of warrant Exercise Price Balance, August 31, 2017 39,191,810 $ 0.09 Expired - - Issued 2,600,000 0.06 Balance, November 30, 2017 41,791,810 $ 0.09 | |
Schedule of Share Based Payment Award Equity Note Warrants or Rights Valuation Assumptions [Table Text Block] | Number Exercise Expiry Outstanding 1 Price Date 2,600,000 $0.06 November 1, 2019 3,454,400 $0.12 April 28, 2019 4,477,500 $0.06 February 28, 2019 1,020,000 $0.06 January 20,2019 2,167,160 $0.15 January 31, 2018 7,227,340 $0.15 February 13, 2018 1,787,640 $0.15 January 30, 2018 637,200 $0.10 and $0.15 after 24 months March 12, 2018 6,882,666 $0.05 and $0.10 after 18 months May 20, 2019 3,253,333 $0.05 and $0.10 after 18 months June 8, 2019 4,288,000 $0.07 August 9, 2018 3,996,571 $0.07 September 23, 2018 41,791,810 |
GOING CONCERN UNCERTAINTY (Narr
GOING CONCERN UNCERTAINTY (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017USD ($) | |
Going Concern Uncertainty 1 | $ 311,241 |
Going Concern Uncertainty 2 | 250,029 |
Going Concern Uncertainty 3 | 193,342 |
Going Concern Uncertainty 4 | 165,712 |
Going Concern Uncertainty 5 | $ 13,435,105 |
MARKETABLE SECURITIES (Narrativ
MARKETABLE SECURITIES (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017USD ($)shares | |
Marketable Securities 1 | shares | 134,000 |
Marketable Securities 2 | $ 25,979 |
Marketable Securities 3 | $ 12,599 |
LONG TERM INVESTMENTS (Narrativ
LONG TERM INVESTMENTS (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017USD ($) | |
Long Term Investments 1 | $ 1 |
MINERAL PROPERTY (Narrative) (D
MINERAL PROPERTY (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017 | |
Mineral Property 1 | 100.00% |
Mineral Property 2 | 100.00% |
LITHIUM TECHNOLOGY (Narrative)
LITHIUM TECHNOLOGY (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017USD ($)dyrshares | |
Lithium Technology 1 | 99.50% |
Lithium Technology 2 | shares | 250,000 |
Lithium Technology 3 | $ 12,500 |
Lithium Technology 4 | 99.50% |
Lithium Technology 5 | d | 30 |
Lithium Technology 6 | $ 10,000 |
Lithium Technology 7 | 96,475 |
Lithium Technology 8 | 96,475 |
Lithium Technology 9 | $ 8,998 |
Lithium Technology 10 | d | 30 |
Lithium Technology 11 | shares | 250,000 |
Lithium Technology 12 | shares | 250,000 |
Lithium Technology 13 | 10.00% |
Lithium Technology 14 | 99.50% |
Lithium Technology 15 | 10.00% |
Lithium Technology 16 | $ 50,000 |
Lithium Technology 17 | 10.00% |
Lithium Technology 18 | $ 150,000 |
Lithium Technology 19 | 10.00% |
Lithium Technology 20 | $ 200,000 |
Lithium Technology 21 | yr | 10 |
Lithium Technology 22 | $ 250,000 |
RELATED PARTY TRANSACTION (Narr
RELATED PARTY TRANSACTION (Narrative) (Details) - 3 months ended Nov. 30, 2017 | USD ($) | CAD |
Related Party Transaction 1 | $ 10,500 | |
Related Party Transaction 2 | 19,500 | |
Related Party Transaction 3 | 0 | |
Related Party Transaction 4 | CAD | CAD 22,500 | |
Related Party Transaction 5 | 148,385 | |
Related Party Transaction 6 | 141,035 | |
Related Party Transaction 7 | 19,523 | |
Related Party Transaction 8 | $ 0 |
COMMON STOCK (Narrative) (Detai
COMMON STOCK (Narrative) (Details) - 3 months ended Nov. 30, 2017 | USD ($)amoshares | CADamoCAD / sharesshares |
Common Stock 1 | shares | 3,858,571 | 3,858,571 |
Common Stock 2 | CAD / shares | CAD 0.035 | |
Common Stock 3 | CAD | CAD 135,050 | |
Common Stock 4 | $ 100,037 | |
Common Stock 5 | mo | 24 | 24 |
Common Stock 6 | $ 0.07 | |
Common Stock 7 | CAD | CAD 4,830 | |
Common Stock 8 | 138,000 | 138,000 |
Common Stock 9 | shares | 175,000 | 175,000 |
Common Stock 10 | $ 7,000 | |
Common Stock 11 | 100.00% | 100.00% |
Common Stock 12 | a | 2,560 | 2,560 |
Common Stock 13 | shares | 1,000,000 | 1,000,000 |
Common Stock 14 | CAD / shares | CAD 0.04 | |
Common Stock 15 | CAD | CAD 40,000 | |
Common Stock 16 | $ 29,630 | |
Common Stock 17 | mo | 24 | 24 |
Common Stock 18 | $ 0.06 | |
Common Stock 19 | CAD | CAD 800 | |
Common Stock 20 | 20,000 | 20,000 |
Common Stock 21 | shares | 4,250,000 | 4,250,000 |
Common Stock 22 | CAD / shares | CAD 0.04 | |
Common Stock 23 | CAD | CAD 170,000 | |
Common Stock 24 | $ 125,926 | |
Common Stock 25 | mo | 24 | 24 |
Common Stock 26 | $ 0.06 | |
Common Stock 27 | CAD | CAD 11,100 | |
Common Stock 28 | 227,500 | 227,500 |
Common Stock 29 | shares | 95,500 | 95,500 |
Common Stock 30 | $ 5,685 | |
Common Stock 31 | 0.05 | |
Common Stock 32 | $ 0.07 | |
Common Stock 33 | shares | 166,500 | 166,500 |
Common Stock 34 | $ 11,655 | |
Common Stock 35 | $ 0.07 | |
Common Stock 36 | shares | 3,224,000 | 3,224,000 |
Common Stock 37 | CAD / shares | CAD 0.09 | |
Common Stock 38 | CAD | CAD 290,160 | |
Common Stock 39 | $ 214,933 | |
Common Stock 40 | mo | 24 | 24 |
Common Stock 41 | $ 0.12 | |
Common Stock 42 | CAD | CAD 20,736 | |
Common Stock 43 | 230,400 | 230,400 |
Common Stock 44 | shares | 2,600,000 | 2,600,000 |
Common Stock 45 | CAD / shares | CAD 0.05 | |
Common Stock 46 | CAD | CAD 130,000 | |
Common Stock 47 | $ 100,893 | |
Common Stock 48 | mo | 24 | 24 |
Common Stock 49 | $ 0.06 | |
Common Stock 50 | shares | 104,898,031 | 104,898,031 |
Common Stock 51 | shares | 102,298,031 | 102,298,031 |
STOCK OPTIONS AND WARRANTS (Nar
STOCK OPTIONS AND WARRANTS (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017USD ($)yrshares | |
Stock Options And Warrants 1 | shares | 1,850,000 |
Stock Options And Warrants 2 | $ 0.05 |
Stock Options And Warrants 3 | shares | 100,000 |
Stock Options And Warrants 4 | $ 0.05 |
Stock Options And Warrants 5 | shares | 800,000 |
Stock Options And Warrants 6 | $ 0.07 |
Stock Options And Warrants 7 | shares | 1,535,000 |
Stock Options And Warrants 8 | $ 0.07 |
Stock Options And Warrants 9 | shares | 1,500,000 |
Stock Options And Warrants 10 | $ 0.07 |
Stock Options And Warrants 11 | shares | 500,000 |
Stock Options And Warrants 12 | $ 0.10 |
Stock Options And Warrants 13 | shares | 800,000 |
Stock Options And Warrants 14 | $ 0.05 |
Stock Options And Warrants 15 | 31,237 |
Stock Options And Warrants 16 | $ 39,646 |
Stock Options And Warrants 17 | shares | 240,000 |
Stock Options And Warrants 18 | $ 12,000 |
Stock Options And Warrants 19 | $ 0 |
Stock Options And Warrants 20 | shares | 2,167,160 |
Stock Options And Warrants 21 | shares | 7,227,340 |
Stock Options And Warrants 22 | shares | 1,000,000 |
Stock Options And Warrants 23 | shares | 1,000,000 |
Stock Options And Warrants 24 | $ 0.09 |
Stock Options And Warrants 25 | 182.00% |
Stock Options And Warrants 26 | 1.22% |
Stock Options And Warrants 27 | yr | 0.5 |
Stock Options And Warrants 28 | 0.00% |
Stock Options And Warrants 29 | $ 29,168 |
Stock Options And Warrants 30 | shares | 95,500 |
Stock Options And Warrants 31 | $ 5,685 |
Stock Options And Warrants 32 | 0.05 |
Stock Options And Warrants 33 | $ 0.07 |
Stock Options And Warrants 34 | shares | 166,500 |
Stock Options And Warrants 35 | $ 11,655 |
Stock Options And Warrants 36 | $ 0.07 |
Stock Options And Warrants 37 | shares | 12,332,571 |
Stock Options And Warrants 38 | shares | 615,900 |
Stock Options And Warrants 39 | $ 33,213 |
Stock Options And Warrants 40 | 168.00% |
Stock Options And Warrants 41 | 1.14% |
Stock Options And Warrants 42 | yr | 2 |
Stock Options And Warrants 43 | 0.00% |
Stock Options And Warrants 44 | shares | 2,600,000 |
COMMITMENTS - OTHER (Narrative)
COMMITMENTS - OTHER (Narrative) (Details) | 3 Months Ended |
Nov. 30, 2017$ / mo | |
Commitments - Other 1 | 5,000 |
Commitments - Other 2 | 6,500 |
Commitments - Other 3 | 3,500 |
Commitments - Other 4 | 10.00% |
SUBSEQUENT EVENT (Narrative) (D
SUBSEQUENT EVENT (Narrative) (Details) - 3 months ended Nov. 30, 2017 | USD ($)moshares | CADmoCAD / sharesshares |
Subsequent Event 1 | shares | 3,954,000 | 3,954,000 |
Subsequent Event 2 | CAD / shares | CAD 0.05 | |
Subsequent Event 3 | CAD | CAD 197,700 | |
Subsequent Event 4 | mo | 24 | 24 |
Subsequent Event 5 | $ | $ 0.06 | |
Subsequent Event 6 | CAD | CAD 12,770 | |
Subsequent Event 7 | 230,400 | 230,400 |
Subsequent Event 8 | mo | 24 | 24 |
Subsequent Event 9 | $ | $ 0.06 |
Schedule of Share-based Compens
Schedule of Share-based Compensation, Stock Options, Activity (Details) | 3 Months Ended |
Nov. 30, 2017USD ($) | |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 1 | $ 7,295,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 2 | 0.07 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 3 | $ 800,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 4 | 0.05 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 5 | $ 8,095,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 6 | 0.07 |
Schedule of Share-based Payment
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) | 3 Months Ended |
Nov. 30, 2017USD ($)yr | |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 | 204.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 | 223.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 | 2.03% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 | 1.22% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 | yr | 5 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 | yr | 5 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 | 0.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 | 0.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9 | $ | $ 0.04 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 10 | $ | $ 0.05 |
Disclosure of Share-based Compe
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) | 3 Months Ended | 12 Months Ended |
Nov. 30, 2017USD ($)yr | Aug. 31, 2017USD ($)yr | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 | $ 800,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 | yr | 4.91 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 | $ 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 | yr | 4.42 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 | $ 1,500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 | yr | 4.17 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 | $ 1,535,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 | yr | 4.14 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 | $ 800,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 | yr | 3.81 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 | $ 1,460,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 | yr | 2.9 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 | $ 1,000,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 | yr | 1.93 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 | $ 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 | $ 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 | yr | 0.93 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 | $ 8,095,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 | yr | 3.4 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 | $ 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 | yr | 4.67 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 | $ 1,500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 | yr | 4.42 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 | $ 1,535,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 | yr | 4.39 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 | $ 800,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 | yr | 4.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 | $ 1,460,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 | yr | 3.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 | $ 1,000,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 | yr | 2.18 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 | $ 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 | $ 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 | yr | 1.18 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 | $ 7,295,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 | yr | 3.43 |
Schedule of Stockholders' Equit
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) | 3 Months Ended |
Nov. 30, 2017USD ($) | |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1 | $ 39,191,810 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2 | 0.09 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3 | $ 0 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4 | 0 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5 | $ 2,600,000 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6 | 0.06 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7 | $ 41,791,810 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8 | 0.09 |
Schedule of Share Based Payment
Schedule of Share Based Payment Award Equity Note Warrants or Rights Valuation Assumptions (Details) | 3 Months Ended |
Nov. 30, 2017USD ($)mo | |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 1 | $ 2,600,000 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 2 | 0.06 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 3 | 3,454,400 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 4 | 0.12 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 5 | 4,477,500 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 6 | 0.06 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 7 | 1,020,000 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 8 | 0.06 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 9 | 2,167,160 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 10 | 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 11 | 7,227,340 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 12 | 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 13 | 1,787,640 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 14 | 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 15 | 637,200 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 16 | 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 17 | $ 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 18 | mo | 24 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 19 | $ 6,882,666 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 20 | 0.05 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 21 | $ 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 22 | mo | 18 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 23 | $ 3,253,333 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 24 | 0.05 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 25 | $ 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 26 | mo | 18 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 27 | $ 4,288,000 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 28 | 0.07 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 29 | 3,996,571 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 30 | 0.07 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 31 | $ 41,791,810 |